内页大图
Home > News >
BMJ is a blockbuster, a new breakthrough in research by Shao Zhimin\'s team of Fudan University, and the survival rate of high-risk patients with triple negative breast cancer has increased by more th

BMJ is a blockbuster, a new breakthrough in research by Shao Zhimin\'s team of Fudan University, and the survival rate of high-risk patients with triple negative breast cancer has increased by more th

At present, breast cancer still ranks first among female tumors in China, seriously endangering the life and health of Chinese women, so it is also known as the \\\"first killer\\\" of women\\\'s health. Although the incidence rate of breas...

2024-11-25